(Q73166090)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Phase I study of liposomal daunorubicin in patients with acute leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

J Cortes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S O'Brien

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Estey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Giles

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Keating

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Kantarjian

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

81-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555126%20AND%20SRC:MED&resulttype=core&format=json

Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia

1 November 2019

cites work

1 reference

12 December 2020

Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes

1 reference

12 December 2020

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

1 reference

12 December 2020

Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes

1 reference

12 December 2020

The biology and treatment of acute lymphoblastic leukemia in adults.

1 reference

12 December 2020

Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia

1 reference

12 December 2020

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases

1 reference

12 December 2020

Role of daunorubicin in the induction therapy for adult acute myeloid leukemia

1 reference

12 December 2020

Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity

1 reference

12 December 2020

A phase I study of daunorubicin in advanced untreatable malignancies

1 reference

12 December 2020

Daunorubicin in the therapy of acute granulocytic leukemia

1 reference

12 December 2020

Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors

1 reference

12 December 2020

Liposomes as carriers of cancer chemotherapy. Current status and future prospects

1 reference

12 December 2020

Treatment of acute myelogenous leukemia and myelodysplastic syndromes

1 reference

12 December 2020

Increased effectiveness of liposome-encapsulated doxorubicin in multidrug-resistant-transgenic mice compared with free doxorubicin

1 reference

12 December 2020

High-dose daunorubicin therapy for acute nonlymphocytic leukemia: correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity.

1 reference

12 December 2020

Treatment and prognostic factors in acute myeloid leukaemia

1 reference

12 December 2020

Effect of liposomes on P-glycoprotein function in multidrug resistant cells

1 reference

12 December 2020

Pharmacology and phase I clinical studies of daunorubicin in patients with advanced malignancies

1 reference

12 December 2020

Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.

1 reference

12 December 2020

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

1 reference

12 December 2020

Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy

1 reference

12 December 2020

Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome).

1 reference

12 December 2020